Hepatic failure: Difference between revisions
(→Drugs) |
Gloria Picoy (talk | contribs) (→Drugs) |
||
Line 45: | Line 45: | ||
*[[Sorafenib]] | *[[Sorafenib]] | ||
*[[Sulfasalazine]] | *[[Sulfasalazine]] | ||
*[[Trovafloxacin mesylate]] | |||
*[[Zafirlukast]] | *[[Zafirlukast]] | ||
Revision as of 21:07, 13 February 2015
Hepatic failure | |
ICD-10 | K72.9 |
---|---|
DiseasesDB | 5728 |
MeSH | D017093 |
WikiDoc Resources for Hepatic failure |
Articles |
---|
Most recent articles on Hepatic failure Most cited articles on Hepatic failure |
Media |
Powerpoint slides on Hepatic failure |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Hepatic failure at Clinical Trials.gov Trial results on Hepatic failure Clinical Trials on Hepatic failure at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Hepatic failure NICE Guidance on Hepatic failure
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Hepatic failure Discussion groups on Hepatic failure Patient Handouts on Hepatic failure Directions to Hospitals Treating Hepatic failure Risk calculators and risk factors for Hepatic failure
|
Healthcare Provider Resources |
Causes & Risk Factors for Hepatic failure |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Liver failure; fulminating hepatic failure
Overview
Liver failure is the inability of the liver to perform its normal synthetic and metabolic function as part of normal physiology.
Classification
Two forms are recognised:[1]
- Acute liver failure - development of hepatic encephalopathy (confusion, stupor and coma) and decreased production of proteins (such as albumin and blood clotting proteins) within four weeks of the first symptoms (such as jaundice) of a liver problem. "Hyperacute" liver failure is said to be present if this interval is 7 days or less, while "subacute" liver failure is said to be present if the interval is 5-12 weeks.
- Chronic liver failure usually occurs in the context of cirrhosis, itself potentially the result of many possible causes, such as excessive alcohol intake, hepatitis B or C, autoimmune, hereditary and metabolic causes (such as iron or copper overload or non-alcoholic fatty liver disease).
Causes
Drugs
- Carfilzomib
- Caspofungin acetate
- Cefadroxil
- Ceftazidime
- Chlordiazepoxide
- Dactinomycin
- Didanosine
- Diflunisal
- Efavirenz
- Fulvestrant
- Gemcitabine
- Indinavir
- Interferon gamma
- Ixabepilone
- Meropenem
- Micafungin sodium
- Oxaprozin
- Oxazepam
- Sorafenib
- Sulfasalazine
- Trovafloxacin mesylate
- Zafirlukast
Prognosis
The King's College criteria (KCC) may be used.
Contraindicated medications
Severe hepatic failure is considered an absolute contraindication to the use of the following medications:
- Carvedilol
- Conjugated estrogens/bazedoxifene
- Diclofenamide
- Dronedarone
- Nebivolol
- Rosuvastatin
- Simvastatin
- Spironolactone
- Hydrochlorothiazide
The ALFSG index is a newer option that may be more accurate.[2]
References
- ↑ O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-5. PMID 8101303.
- ↑ Rutherford A, King LY, Hynan LS, Vedvyas C, Lin W, Lee WM; et al. (2012). "Development of an accurate index for predicting outcomes of patients with acute liver failure". Gastroenterology. 143 (5): 1237–43. doi:10.1053/j.gastro.2012.07.113. PMC 3480539. PMID 22885329.